National Heart Centre Singapore
Singapore, Singapore
7 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Heart Failure
Novo Nordisk A/S5,600 enrolled1117 locationsNCT05636176
Recruiting
Not Applicable
Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care
Heart Failure
National Cancer Centre, Singapore240 enrolled4 locationsNCT06244953
Recruiting
Not Applicable
SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)
Lung Cancer
National Cancer Centre, Singapore1,000 enrolled3 locationsNCT05724264
Recruiting
Phase 2
Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body
Heart FailureCardiometabolic SyndromeCardiovascular Diseases+2 more
National Heart Centre Singapore200 enrolled1 locationNCT06645691
Recruiting
Not Applicable
Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes
Diabetes Mellitus, Type 2
Singapore General Hospital400 enrolled3 locationsNCT06028139
Recruiting
Response of the Myocardium to Hypertrophic Conditions in the Adult Population
HypertensionLeft Ventricular HypertrophyMyocardial Fibrosis
National Heart Centre Singapore2,000 enrolled1 locationNCT02670031